APM
MNTA

Avidity Partners Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Avidity Partners Management’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,150,000
Closed -$38.3M – 100
2020
Q2 		$38.3M Buy
1,150,000
+370,000
+47% +$11.8M 2.45% 11
2020
Q1 		$21.2M Buy
780,000
+580,000
+290% +$16.1M 2.93% 10
2019
Q4 		$3.95M Buy
+200,000
New +$3.2M 2.49% 19

Other funds holding MNTA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
HBK Investments
HBK Investments Dallas, Texas $10.3B AUM 67.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Pentwater Capital Management
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Magnetar Financial
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Avidity Partners Management's MNTA Position: Q3 2020 in Review

Avidity Partners Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2020, closing a stake of 1,150,000 shares — an estimated $38.3M sold.

Avidity Partners Management first reported a position in MNTA in Q4 2019 and held it in 3 quarters. The position peaked at $38.3M in Q2 2020. 211 funds tracked by Wall St. Rank hold MNTA as of Q3 2020.

  • Avidity Partners Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Avidity Partners Management sold 1,150,000 Momenta Pharmaceuticals, Inc. shares in Q3 2020, an estimated $38.3M.
  • Avidity Partners Management first reported a position in Momenta Pharmaceuticals, Inc. in Q4 2019 and held it in 3 quarters.
  • Avidity Partners Management's Momenta Pharmaceuticals, Inc. position peaked at $38.3M in Q2 2020.
  • 211 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2020.

Based on Avidity Partners Management's 13F filing for Q3 2020, filed 16 Nov 2020.